{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/129492"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/129492","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Engineering extracellular vesicles and immune cell homing materials for next generation cancer immunotherapy","abstract":"Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2027-05-01","abstract_html":"Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2027-05-01","abstract_has_math":false,"creators":["Bhatta, Rimsha"],"institution":"University of Illinois Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Materials Science & Engr","degree_department":null,"school":null,"contributors":["Wang, Hua","Leal, Cecilia","Chen, Qian","Bhargava, Rohit","Nelson, Erik R."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025-02-21","date_published":"2025-02-21","updated_at":"2026-07-22T22:25:05Z","subjects":["Cancer Immunotherapy","Biomaterial","Hydrogel","Extracellular Vesicle","Dendritic Cell"],"languages":["en","eng"],"rights":["Copyright 2025 Rimsha Bhatta"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2142/129492","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Wang, Hua","Leal, Cecilia","Chen, Qian","Bhargava, Rohit","Nelson, Erik R."]},{"key":"dc:creator","label":"Author","values":["Bhatta, Rimsha"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025-02-21","2025-05"]},{"key":"dc:type","label":"Dc Type","values":["text","Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Materials Science & Engr"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Cancer Immunotherapy","Biomaterial","Hydrogel","Extracellular Vesicle","Dendritic Cell"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en","eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2025 Rimsha Bhatta"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://hdl.handle.net/2142/129492"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2027-05-01","The student, Rimsha Bhatta, accepted the attached license on 2025-02-17 at 14:42.","The student, Rimsha Bhatta, submitted this Dissertation for approval on 2025-02-17 at 14:47.","This Dissertation was approved for publication on 2025-02-21 at 10:38.","DSpace SAF Submission Ingestion Package generated from Vireo submission #21643 on 2025-10-19 at 19:14:15","My Ph.D. research focuses on developing innovative technologies to enable precise and effective modulation of dendritic cells (DCs), to advance cancer immunotherapies that elicit durable cytotoxic T lymphocyte (CTL) responses and robust antitumor efficacy. My work spans two key material platforms: nanosized extracellular vesicles (EVs) and macroscale immune cell-homing biomaterials. For EVs, I developed a novel metabolic tagging technology that installs chemical tags (e.g., azido groups) onto the surface of cell-secreted exosomes, enabling the conjugation of immunomodulatory agents through efficient click chemistry. This approach allows for the functionalization and modulation of EVs to enhance their processing by DCs, leading to improved T-cell priming and antitumor activity. For immune cell-homing biomaterials, I designed a prototype cancer immunotherapy platform using DC-homing macroporous hydrogels with tunable pore size and mechanical properties. Together, these technologies aim to provide tailored solutions for enhancing immune responses and overcoming challenges in cancer immunotherapy. Chapter I introduces the foundational concepts of this research and outlines the current challenges and limitations in the field of cancer immunotherapy. Chapter II explores metabolic tagging and targeting strategies for extracellular vesicles (EVs), focusing on the development of next-generation EV vaccines. By conjugating adjuvants (e.g., CpG) to EVs, we demonstrate the induction of robust cytotoxic T lymphocyte (CTL) responses and enhanced antitumor efficacy. Building on this, Chapter III investigates the potential of antibody-conjugated tumor EVs (e.g., anti-DEC205) as therapeutic cancer vaccines, improving the targeting efficiency and activation of dendritic cells (DCs). Chapter IV extends this work by leveraging chemically tagged exosomes to develop exosome-based hydrogels, which function as potent in situ depot vaccines for sustained immune modulation. In parallel, Chapter V delves into the rational design of immune cell-homing macroporous materials, which preferentially recruit specific immune cells (e.g., DCs) to the material site in vivo, serving as a prototype for cancer immunotherapy. Finally, Chapter VI highlights the ability of these immune cell-homing materials to recruit and modulate T cells in vivo, supporting the development of advanced T cell therapies. Together, these chapters present a comprehensive approach to advancing cancer immunotherapy through innovative biomaterial and EV-based strategies."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Engineering extracellular vesicles and immune cell homing materials for next generation cancer immunotherapy"]}]}],"canonical_facts":{"dc:contributor":["Wang, Hua","Leal, Cecilia","Chen, Qian","Bhargava, Rohit","Nelson, Erik R."],"dc:creator":["Bhatta, Rimsha"],"dc:date":["2025-02-21","2025-05"],"dc:description":["Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2027-05-01","The student, Rimsha Bhatta, accepted the attached license on 2025-02-17 at 14:42.","The student, Rimsha Bhatta, submitted this Dissertation for approval on 2025-02-17 at 14:47.","This Dissertation was approved for publication on 2025-02-21 at 10:38.","DSpace SAF Submission Ingestion Package generated from Vireo submission #21643 on 2025-10-19 at 19:14:15","My Ph.D. research focuses on developing innovative technologies to enable precise and effective modulation of dendritic cells (DCs), to advance cancer immunotherapies that elicit durable cytotoxic T lymphocyte (CTL) responses and robust antitumor efficacy. My work spans two key material platforms: nanosized extracellular vesicles (EVs) and macroscale immune cell-homing biomaterials. For EVs, I developed a novel metabolic tagging technology that installs chemical tags (e.g., azido groups) onto the surface of cell-secreted exosomes, enabling the conjugation of immunomodulatory agents through efficient click chemistry. This approach allows for the functionalization and modulation of EVs to enhance their processing by DCs, leading to improved T-cell priming and antitumor activity. For immune cell-homing biomaterials, I designed a prototype cancer immunotherapy platform using DC-homing macroporous hydrogels with tunable pore size and mechanical properties. Together, these technologies aim to provide tailored solutions for enhancing immune responses and overcoming challenges in cancer immunotherapy. Chapter I introduces the foundational concepts of this research and outlines the current challenges and limitations in the field of cancer immunotherapy. Chapter II explores metabolic tagging and targeting strategies for extracellular vesicles (EVs), focusing on the development of next-generation EV vaccines. By conjugating adjuvants (e.g., CpG) to EVs, we demonstrate the induction of robust cytotoxic T lymphocyte (CTL) responses and enhanced antitumor efficacy. Building on this, Chapter III investigates the potential of antibody-conjugated tumor EVs (e.g., anti-DEC205) as therapeutic cancer vaccines, improving the targeting efficiency and activation of dendritic cells (DCs). Chapter IV extends this work by leveraging chemically tagged exosomes to develop exosome-based hydrogels, which function as potent in situ depot vaccines for sustained immune modulation. In parallel, Chapter V delves into the rational design of immune cell-homing macroporous materials, which preferentially recruit specific immune cells (e.g., DCs) to the material site in vivo, serving as a prototype for cancer immunotherapy. Finally, Chapter VI highlights the ability of these immune cell-homing materials to recruit and modulate T cells in vivo, supporting the development of advanced T cell therapies. Together, these chapters present a comprehensive approach to advancing cancer immunotherapy through innovative biomaterial and EV-based strategies."],"dc:format":["application/pdf"],"dc:identifier":["https://hdl.handle.net/2142/129492"],"dc:language":["en","eng"],"dc:rights":["Copyright 2025 Rimsha Bhatta"],"dc:subject":["Cancer Immunotherapy","Biomaterial","Hydrogel","Extracellular Vesicle","Dendritic Cell"],"dc:title":["Engineering extracellular vesicles and immune cell homing materials for next generation cancer immunotherapy"],"dc:type":["text","Thesis"],"thesis:degree_discipline":["Materials Science & Engr"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois Urbana-Champaign"]},"updated_at":"2026-07-22T22:25:05Z"}